Results 101 to 110 of about 29,238 (215)

Pneumonia por pneumocystis jiroveci [PDF]

, 2006
A Pneumonia por Pneumocystis jiroveci surge como uma patologia oportunista, muito frequente de indivíduos, principalmente daqueles infectados com VIH que entram na fase de SIDA.
Rodrigues, Francisco
core  

Pneumocystis Jirovecii Pneumonia in Two Immunosuppressed Non-HIV Infected Patients: A Clinical and Therapeutic Analysis

Weiran Li, Mao Hua, Jin Guo, Wenbo Jia Department of Clinical Medicine, School of Medicine, Qinghai University, Xining, People’s Republic of ChinaCorrespondence: Mao Hua, Qinghai University Affiliated Hospital, No.
Li W, Guo J, Jia W, Hua M
core  

Kaplan-Meier survival curve for the patients with pneumocystis pneumonia.

, 2015
Kaplan-Meier survival curve for the patients with pneumocystis pneumonia.
Kai-Feng Xu (305907), Minjiang Chen (801669), Xinlun Tian (305900), Jinjing Liu (801671), Mengzhao Wang (801672), Fang Qin (141228), Jiong Zhou (801670)   +6 more
core   +1 more source

Description of a Murine Model of Pneumocystis Pneumonia

International audiencePneumocystis pneumonia is a serious lung infection caused by an original ubiquitous fungus with opportunistic behavior, referred to as Pneumocystis jirovecii. P. jirovecii is the second most common fungal agent among invasive fungal
Desoubeaux, Guillaume, Baranek, Thomas, Parent, Christelle, Gonzalez, Loïc, Chesnay, Adélaïde   +4 more
core   +1 more source

Low prevalence of Pneumocystis pneumonia in hospitalized patients with systemic lupus erythematosus: review of a clinical data warehouse.

, 2017
Objective In the era of powerful immunosuppression, opportunistic infections are an increasing concern in systemic lupus erythematosus. One of the best-studied opportunistic infections is Pneumocystis pneumonia; however, the prevalence of Pneumocystis ...
Mahadeshwar, Pooja, J Giles, A Askanase, J Bathon, P Mahadeshwar, Li, J, Kapoor, T M, S Kapoor, Giles, J, Nguyen, S, J Li, Askanase, A, Kapoor, S, Bathon, J, S Nguyen, T M Kapoor   +15 more
core   +1 more source

Study on mNGS Technique in Diagnosing Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients

Shuai Li, Xue Han, Jing Ma, Guo-Hong Huang, Shu-Ting Yang, Chang-Min Wang Clinical Laboratory Center, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, 830001, People’s Republic of ChinaCorrespondence: Chang-Min Wang, Department of
Li S, Huang GH, Wang CM, Han X, Ma J, Yang ST   +5 more
core  

Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy

, 2018
Pneumocystis jirovecii pneumonia is a life-threatening opportunistic infection in children receiving immunosuppressive chemotherapy.
William Greene, J. T. Fannin, Allison Bragg, Patrick K. Campbell, Kristine R. Crews, Joseph Sciasci, Jennifer L. Pauley, Melissa Quinn, Sima Jeha, Delia Carias, David Gregornik, Gabriela Maron, Joshua Wolf, Hope D. Swanson   +13 more
core   +1 more source

Usefulness of (1,3) beta-D-glucan detection in bronchoalveolar lavage samples in Pneumocystis pneumonia and Pneumocystis pulmonary colonization

, 2015
International audienceObjective of the study. - Recent data demonstrate the usefulness of (1,3) beta-D-glucan (BG) Bronchoalveolar lavage detection in serum samples to distinguish patients developing Pneumocystis pneumonia and samples; patients who are ...
da Costa, C., Di Pizio, P., Le Gal, S., Bach, Véronique, Virmaux, M., Totet, Anne, Goin, N., Stephan, Erwan, Nevez, G., Damiani, C.   +9 more
core   +1 more source

Pneumocystis Pneumonia. Literature Review.

Pneumocystis jirovecii pneumonia is a potentially life-threatening opportunist fungal infection, which mainly affects immunocompromised patients. It became more known during the HIV/AIDS pandemic which started in 1981, but in later years its impact on ...
Wagner, Felix Christian,
core  

Pneumocystis pneumonia.

, 2002
Pneumocystis jiroveci is a common cause of pneumonia in South African patients with AIDS. Sulphonamide resistance may become a problem in South Africa, as patients are treated with prophylactic co-trimoxazole when their CD4 counts fall below 200 cells ...
Robberts F.J., Chalkley L.J., Liebowitz L.D.   +2 more
core